DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Sepah YJ, Sadiq MA, Boyer D. et al.
Twenty-four–month outcomes of the ranibizumab for edema of the macula in diabetes–protocol 3 with high dose (READ-3) study.
Ophthalmology 2016;
123: 2581-2587
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.